Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company’s Phase 1b...
The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of...
Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
COSTA MESA, Calif., July 28, 2025 /PRNewswire/ -- The newly founded Stuttering Treatment and Research Society (STARS) announced it is the...
Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment platform to payers, pharma, wellness...
Bringing early detection of cognitive impairment to the forefront of health plan CX — empowering personalized, proactive brain health BOSTON...
Analysis of first-in-class CNS-101 study validates that at-home endpoints showed greater separation with Alzheimer's pathology (pTau217) than the benchmark endpoint...
ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"),...
TORONTO, July 27, 2025 /PRNewswire/ -- The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025...
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition and a groundbreaking...
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for the treatment of ambulatory individuals with Duchenne muscular...
Spanning 11 studies across the U.S., Canada, Sweden, and Australia, the newly funded research explores interventions for young people dealing...
Harnessing Voice Analysis, NuCalm's Breakthrough Technology Determines Your Stress Level with Ease and Accuracy LOS ANGELES, July 23, 2025 /PRNewswire/...
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)...
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)...
Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences,...
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics...
MIDDLETON, Wis., July 22, 2025 /PRNewswire/ -- Natus Medical Incorporated is continuing its commitment to innovation and expanding the functionality of...
NEW ORLEANS, July 22, 2025 /PRNewswire/ -- Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative...
Powering Alzheimer's research with AI-driven insights across cognition, meaning, motor function, and speech — accelerating study recruitment and enabling more...